Evidence map›Paper›PMID 42191833›Full record

ArticleScientific reports2026

Genomic characterization of Enterotoxigenic Escherichia coli lineage 2 (CS2 + CS3) by long-read sequencing reveals distinct lineage-specific genome organization.

Nayyer Taheri, Åsa Sjöling

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nayyer TaheriDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden. nayyer.taheri@gu.se.
Åsa SjölingDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhoea in children, adults and travellers in endemic regions. ETEC pathogenesis is mediated by heat-labile (LT) and heat-stable (ST) enterotoxins together with colonization factors. In this study, we characterized the chromosomal and plasmid features of twelve ETEC lineage 2 (L2) isolates, including five isolates sequenced by long-read PacBio technology and reported for the first time in this study, and seven publicly available complete genomes. Comparative genomic analysis revealed a highly conserved chromosomal backbone and two core plasmids, with the CS2 operon uniquely integrated into the chromosome, while other virulence determinants, including LT, ST, CS3, EatA, CS21, and EtpBAC remained plasmid-encoded. Fusion and consolidation of lineage 1-like plasmids produced a streamlined plasmidome in L2, preserving essential virulence genes while occasionally incorporating antibiotic resistance determinants. Phage-like plasmids were identified sporadically, highlighting ongoing horizontal gene acquisition. These findings demonstrate that ETEC L2 employs a hybrid virulence architecture combining chromosomal fixation of a key colonization factor with plasmid-mediated accessory traits, potentially enhancing stability and transmissibility. The study provides new insights into the genomic organization, evolutionary dynamics, and pathogenic potential of this emerging ETEC lineage.

Indexed as

Enterotoxigenic Escherichia coliGenome, BacterialChromosomes, BacterialEscherichia coli InfectionsGenomicsHumansPhylogenyPlasmidsVirulenceVirulence FactorsVirulence FactorsARGsCS2CS3ETECL2

Identifiers

PMID42191833
PMCPMC13212926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.